194 related articles for article (PubMed ID: 25894544)
21. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas.
Qian ZR; Asa SL; Siomi H; Siomi MC; Yoshimoto K; Yamada S; Wang EL; Rahman MM; Inoue H; Itakura M; Kudo E; Sano T
Mod Pathol; 2009 Mar; 22(3):431-41. PubMed ID: 19136928
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs and Target Genes in Pituitary Adenomas.
Feng Y; Mao ZG; Wang X; Du Q; Jian M; Zhu D; Xiao Z; Wang HJ; Zhu YH
Horm Metab Res; 2018 Mar; 50(3):179-192. PubMed ID: 29351706
[TBL] [Abstract][Full Text] [Related]
23. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
24. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
25. Roles of HMGA proteins in cancer.
Fusco A; Fedele M
Nat Rev Cancer; 2007 Dec; 7(12):899-910. PubMed ID: 18004397
[TBL] [Abstract][Full Text] [Related]
26. HMGA1 and HMGA2 protein expression in mouse spermatogenesis.
Chieffi P; Battista S; Barchi M; Di Agostino S; Pierantoni GM; Fedele M; Chiariotti L; Tramontano D; Fusco A
Oncogene; 2002 May; 21(22):3644-50. PubMed ID: 12032866
[TBL] [Abstract][Full Text] [Related]
27. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
28. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
29. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
[TBL] [Abstract][Full Text] [Related]
31. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival.
Xu M; Shorts-Cary L; Knox AJ; Kleinsmidt-DeMasters B; Lillehei K; Wierman ME
Endocrinology; 2009 May; 150(5):2064-71. PubMed ID: 19116338
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Mei Y; Bi WL; Greenwald NF; Du Z; Agar NY; Kaiser UB; Woodmansee WW; Reardon DA; Freeman GJ; Fecci PE; Laws ER; Santagata S; Dunn GP; Dunn IF
Oncotarget; 2016 Nov; 7(47):76565-76576. PubMed ID: 27655724
[TBL] [Abstract][Full Text] [Related]
34. [The expression of pseudogene HMGA1L2 in thyroid lesions].
Wang GL; Zhang GC; Li F; Zhao J; Hu WH; Zhang JF; Yin XL; Guo CJ; Jiang JF; Liang WH
Yi Chuan; 2006 Nov; 28(11):1365-70. PubMed ID: 17098703
[TBL] [Abstract][Full Text] [Related]
35. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma.
Zhang Y; Liu YT; Tang H; Xie WQ; Yao H; Gu WT; Zheng YZ; Shang HB; Wang Y; Wei YX; Wu ZR; Wu ZB
J Clin Endocrinol Metab; 2019 Dec; 104(12):6345-6356. PubMed ID: 31369093
[TBL] [Abstract][Full Text] [Related]
36. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
37. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
38. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
39. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]